chrisvoncsefalvay/vaers-outcomes huggingface dataset:
excruciating pain from my shoulder to my wrist down the entire arm; It's just feel like a nerve pain not just soreness; I cannot use my hand; I cannot move the left arm with this pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 80 year-old female patient received bnt162b2 (BNT162B2), administration date 12Mar2021 (Batch/Lot number: unknown) at the age of 80 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 12Mar2021, outcome "not recovered", described as "excruciating pain from my shoulder to my wrist down the entire arm"; NEURALGIA (non-serious) with onset 12Mar2021, outcome "not recovered", described as "It's just feel like a nerve pain not just soreness; I cannot use my hand"; PAIN (non-serious) with onset 12Mar2021, outcome "not recovered", described as "I cannot move the left arm with this pain". Therapeutic measures were taken as a result of pain in extremity, neuralgia, pain.  Additional Information: The reporter stated, "I had my first vaccine, approximately one hour after the vaccination I have had excruciating pain from my shoulder to my wrist down the entire arm and this is over three weeks now almost I cannot move the left arm with this pain. Well it's just everyone is little away it's just feel like a nerve pain not just soreness I am in a shaft I cannot use my hand without using a pain pill I have taken Tylenol does help once".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Rash on arms and torso consistent with mild VARICELLA vaccine on 3/2/09, onset of rash 3/7/09.  No other symptoms.
A report has been received from a Health Professional concerning a Child, Male subject, who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST started on an unknown date. The patient experienced stomach virus. The patient recovered from the event of stomach virus on an unspecified date. The report was considered to be non-serious by the reporter.
Patient given Rotarix vaccine. On first dose of Rotarix, my baby had symptoms of vomiting, blood in stools. These symptoms stopped after giving antibiotic. Same symtoms recurred again the next month - Again antiobiotic treatment. On second dose of Rotarix, again blood in stools, loose motions and fever.
p/ pt recv vax approx 18 days later pt devel ``40 active vesicles that were red, raised, some fluid-filled''. MD noted pt was itchy. pt treated w/benadryl
From initial information received on 4/28/04 from a health care facility regarding an adverse event occurring in the USA, it was reported that a 45 year old male patient received his third dose of post-exposure IMOVAX RABIES series, lot number X0582-2, administered IM in the left deltoid on 4/7/04. A few hours later, the patient experienced generalized aches lasting no longer than 24 hours, which then subsided. The same scenario was experienced with dose 4 on 4/10/04, dose 5 on 4/13/04, dose 6 on 4/20/04 and dose 7 on 4/27/04, lot numbers were not reported. The patient recovered from these events.
Severe headache - 24 hours (4/3 - 4/4) Body aches - 24 hours (4/3 - 4/4) Severe lower abdominal pain - 24 hours (4/4-4/5) loss of appetite - several days (4/4 - 4/9) diarrhea - one day (4/8)
Body aches, low-grade temp, headache, and nausea- x 48hrs
Sharp pain in lower left calf, Over time have experienced on a daily basis tingling, burning, numbing, heavy, cramping, weakness, painful left and right legs.
A first dose of the Moderna COVID-19 vaccine was administered beyond the beyond-use-date.  The adverse event the patient experienced was nothing but the usual injection site pain (The patient came into the pharmacy earlier today for another reason before the error was identified, and I inquired into his status).  Specific details listed below: the date at which it was defrosted (04/20/2021);  the beyond use date (05/20/2021; 30 days after defrost);  the manufacture's expiration date (10/12/2021);  the number of patients that received the doses of the vial (1 patient only);  if they were first or second doses (1st dose); the date at which it was administered (05/26/2021); Injection site (right deltoid); and lastly the fact that it was at refrigerated temperatures from the time it was defrosted until the time it was administered (26 days).)
KNOT AT INJECTION SITE; SORE ARM; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose was not reported, administered on 19-JUL-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On JUL-2021, the subject experienced knot at injection site. On JUL-2021, the subject experienced sore arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the sore arm and knot at injection site was not reported. This report was non-serious.
tested positive for Rheumatoid Arthritis; body aches; muscle pain; joint pain; nerve pain; fingertips and toes were very painful-burning sensation; fingertips and toes were very painful-burning sensation; Underarm pain-throbbing; skin hurt when applying lotion; Low grade fever 99.9; This is a spontaneous report from a contactable other healthcare professional (patient).  A 62-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL9262), intramuscularly at right arm on 29Jan2021 11:00 at single dose for COVID-19 immunization at workplace clinic. The patient's medical history included autoimmune disorder, kidney disease, angina, and high blood pressure. There were other medications that the patient received within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Known allergies: Simvastatin, Tramadol, Codeine. Historical vaccine included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL1283), at the age of 62-year-old, intramuscularly at right arm on 09Jan2021 13:15 at single dose for COVID-19 immunization at workplace clinic. It was reported that on the 2nd day after the vaccine (30Jan2021 13:00) patient started having body aches, muscle pain, joint pain, nerve pain. Her fingertips and toes were very painful-burning sensation. Also reported underarm pain-throbbing. Her skin hurt when applying lotion. Had low grade fever 99.9. Treatment was received for the above mentioned events: Tylenol 500mg, 2 Caps Q6h. Patient was recovering from the above mentioned events. She do have an autoimmune disorder: her Rheumatologist is checking for Psoriatic arthritis. She had tested positive for Rheumatoid Arthritis (unknown outcome). No treatment for this condition at this time. The patient was not pregnant at the time of reporting, not pregnant at the time of vaccination. The patient was not diagnosed with COVID-19 or not prior to vaccination. The patient had not been tested for COVID-19 since the vaccination.; Sender's Comments: Based on the information available, a possible contributory role of the suspect BNT162B2 at 2nd injection cannot be excluded for the reported events based on the known safety profile and the plausible temporal relationship.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Constant chest pain since initial Vaccine given 1-21-21, second does on 2-12-21, and booster received 12-21-21.  Have had multiple chest xrays, CT scans, ER visits for chest pain, been prescribed medications, and have  had multiple blood tests.  I have a diagnosis now of Tachycardia, and will be having to wear a heart monitor for two weeks, starting tomorrow, 2/18/22.  I will also be having coronary CTA on 2-18-22.
Since the first dose on 02/24/2021 the day after my eye felt sensitive to touch and painful and the next day I could not even open my eyes. After 3 days, I went to my doctor and she stated I had an extreme case of uveitis and it took about 3 weeks for my eyes to be fine again. When I took the 2nd dose, it came back. The eye doctor looked at it and said the same thing and gave me the drops and I took it every hour on the hour for about 3 days until I was a bit better. With the booster the same thing. Since I had the drops I was able to eliminate the symptoms in 4 days however now my right eye is not the same, it is blurrier and it seems like every time I take a dose, it gets worse and worse. I also took a shingles vaccine recently after the booster and the same thing now happened, which is not something that happened prior to taking the vaccine. Also, recently I had a cold and it came back out of nowhere. Still trying to figure out what triggered it.
This spontaneous report as received from a other health professional refers to a patient of unknown age. On an unknown date the patient was vaccinated with PROQUAD for prophylaxis. Other suspect therapies included VARIVAX. On an unknown date the patient experienced incorrect product storage and no adverse event. The outcome of incorrect product storage and no adverse event is unknown. The reporter considered incorrect product storage to be not related to PROQUAD and VARIVAX. The reporter considered no adverse event to be not related to VARIVAX and PROQUAD. Additional information is not expected.
Diarrhea; A spontaneous report was received from a consumer concerning a 76-year-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced diarrhea.  The patient's medical history was not provided. Concomitant medications were not reported.  On 04 Jan 2021, the patient received their first of two planned doses of mRNA-1273 (Lot Number: 11L20A) for the prophylaxis of COVID-19 infection.  On 04 Jan 2021, after receiving the vaccine, the patient experienced diarrhea. Treatment information was not provided.  Action taken with mRNA-1273 in response to the event was not reported.   The outcome of the event diarrhea was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the event of diarrhea, a causal relationship cannot be excluded.
Symptoms: Bilateral Trochanteric Bursitis and Bilateral IT Bands tenderness.  I had taken a Medrol pack for a week with mild relief.  I rested them, but walking, standing after being seated for a while, steps, treadmill dancing, all these things I use to do are now painful.  They are not getting better.  I spoke to 2 others with this problem.   Tender to touch.  I can't dance Salsa or Bachatta now, as I had.
And this month I start to spotting couple of days and now stopped again; I suppose to have period on march 20th after first shot. After my first and 2nd shot, I totally missed my period.; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 07Mar2021 at 10:00 (at the age of 44-years-old) as a single dose for COVID-19 immunisation and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28Mar2021 at 10:00 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 22Mar2021, the patient reported that she was suppose to have period on March 20th.  After her first and 2nd shot, she totally missed her period and on an unknown date in Apr2021, she start to spotting couple of days and now stopped again. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event suppose to have period on march 20th, after her first and 2nd shot, she totally missed her period and she start to spotting couple of days and now stopped again was not resolved at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
EXCESSIVE SWELLING OF RIGHT DELTOID MUSCLE AND RIGHT SHOULDER AREA (VACCINE INJECTED INTO RIGHT DELTOID), EXTREME PAIN, WARM TO TOUCH, RIGHT DELTOID AND SHOULDER AREA PINK IN COLOR, PAIN AND TENDERNESS AT INJECTION SITE, VERY LIMITED RANGE OF MOTION IN RIGHT ARM.
Patient had severe pain in right arm such that she could not move her arm, weakness in arm. With left arm, patient can move her right.
My son wet the bed 2 nights in a row after vaccine, this has never happened before; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 7 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 12Nov2021 18:45 (Batch/Lot number: unknown) at the age of 7 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing); "premature birth" (unspecified if ongoing); "Lactose intolerance" (unspecified if ongoing), notes: Known allergies: Lactose allergy. The patient's concomitant medications were not reported. The following information was reported: ENURESIS (non-serious) with onset 13Nov2021 22:45, outcome "unknown", described as "My son wet the bed 2 nights in a row after vaccine, this has never happened before". Therapeutic measures were not taken as a result of enuresis.  Additional information: Facility type vaccine was pharmacy or drug store. The patient had no other vaccine in four weeks and no other medications in two weeks. The patient had no COVID prior vaccination and not tested COVID post vaccination.  The lot number for vaccine [BNT162B2] was not provided and will be requested during follow-up. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a physician concerning a 29 year old female (also reported as a 6-year-old) with an amoxicillin allergy and no pertinent medical history who on 13-AUG-2007 (also reported as 01-AUG-2007) was vaccinated intramuscularly in the left deltoid (arm) with a dose of ZOSTAVAX (Lot#657675/0618U). This was due to nursing error. There was no concomitant medication. On 13-AUG-2007 the patient developed injection site warmth, tenderness and redness. The patient took ADVIL and/or TYLENOL for the injection site reaction. Subsequently, the patient recovered. No further information was provided. There was no product quality complaint involved. Additional information has been received from the physician who stated that the patient was vaccinated with a dose of ZOSTAVAX instead of a dose of VARIVAX. The patient reported redness, mild pain at the injection site after vaccination. The physician stated that it was an error by the medical assistant (also reported as a new nurse). The error was found when the patient came in June 2007 for her second dose of VARIVAX. No diagnostic laboratory tests were undertaken. This is a consolidation of two reports concerning the same patient. No further information is expected.
Sick all night of first night, body aches, fever, chills, throwing up; Next day,  tongue and lips swelled up; Next week, hair started falling out in clumps for a month; After the month of loss of hair, now have brittle hair
On the seventh day after the vaccination patienthad a fever of 103.2 and a rash on his neck, back and stomach along with swollen lymph nodes.  The fever and rash lasted until Sunday, September 7, 2003.  The emergency room said it was due to his MMR shot.  He also had a HIB, HEP B, and Prevnar shot along with the MMR shot.
Vaccines given to L deltoid, 12/18/02 . On 12/19/02 teacher noted swollen, redness, warm L deltoid area. No improvement and symptom with cool compresses and Tylenol 12/20/02 L deltoid extremely swollen, redness to L elbow and L anterior shoulder, no prescribed antibio, tx.
Erythema Multiforma, Prednisone and a steroid cream along with a skin punch biopsy
Injection site sore since injection (left arm). Tired. Began feeling achy around 7pm. Took temperature at 9:30pm and it was 100.2. No treatment yet.
mom called 6PM Monday & said pt leg was red- 1/2 dollar size-1/2 inch away from inj site
I had nasal congestion, chest congestion with cough, and just fatigue. I would just get so tired I would have to take a nap. They were relatively mild. I did have the antibody infusion.  The symptoms started out as if I had an allergy on Monday 21st but then the cough got deeper with more congestion. On the 24th, I tested positive. On the 25th, I had the antibody infusion and felt progressively better. I still have times of being tired.
CONTINUOUS DIARRHEA INITIALLY/DIARRHEA OFF AND ON; COUGH; SLIGHT HEADACHE; NAUSEA; FEVER UP TO 100.3; VACCINE DRAW UP THE SYRINGE WITH 1.5 ML OR MORE/GIVEN AN OVERDOSE OF VACCINE; CHILLS (FELT LIKE COMING DOWN WITH A COLD); ACHES AND PAINS; This spontaneous report received from a patient concerned a 67 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1820095, expiry: UNKNOWN) dose was not reported, administered on 12-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On 12-MAY-2021, the subject experienced aches and pains. On 12-MAY-2021, the subject experienced vaccine draw up the syringe with 1.5 ml or more/given an overdose of vaccine. On 12-MAY-2021, the subject experienced chills (felt like coming down with a cold). On 13-MAY-2021, the subject experienced continuous diarrhea initially/diarrhea off and on. On 13-MAY-2021, the subject experienced cough. On 13-MAY-2021, the subject experienced slight headache. On 13-MAY-2021, the subject experienced nausea. On 13-MAY-2021, the subject experienced fever up to 100.3. Laboratory data included: Body temperature (NR: not provided) UP TO 100.3. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from aches and pains, and chills (felt like coming down with a cold) on 17-MAY-2021, and slight headache, nausea, and fever up to 100.3 on 16-MAY-2021, had not recovered from continuous diarrhea initially/diarrhea off and on, and cough, and the outcome of vaccine draw up the syringe with 1.5 ml or more/given an overdose of vaccine was not reported. This report was non-serious.
Left arm pain from shoulder to elbow; extreme fatigue; headache; joint pain; chills; low grade fever; nausea; This is a spontaneous report from a contactable Other HCP reported for herself (patient). This 58-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: EL1284), via an unspecified route of administration from 07Jan2021 at 15:45 at single dose on left arm for COVID-19 immunisation. Medical history included COVID-19 and was sick for 17 days, no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received unspecified concomitant medications. The patient experienced left arm pain from shoulder to elbow, extreme fatigue, headache, joint pain, chills, low grade fever, nausea on 07Jan2021 at 21:00. Symptoms started five hours after injection and did not abate until about 64 hours after vaccination. No treatment was received for the events and all considered as non-serious. The outcome of the events was recovered in Jan2021.
she developed feeling hot; developed a cold sore; developed shivering; This case was reported by a consumer via call center representative and described the occurrence of cold sores in a 66-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Cold sores (cold sore related to stress).   On 7th December 2020, the patient received the 1st dose of Shingrix .5 ml. On 7th December 2020, less than a day after receiving Shingrix, the patient experienced cold sores (serious criteria clinically significant/intervention required) and shivering (serious criteria clinically significant/intervention required). On 8th December 2020, the patient experienced feeling hot (serious criteria clinically significant/intervention required). The patient was treated with acyclovir and paracetamol (Acetaminophen). On 8th December 2020, the outcome of the shivering and feeling hot were recovered/resolved. On an unknown date, the outcome of the cold sores was not recovered/not resolved.   It was unknown if the reporter considered the cold sores, shivering and feeling hot to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix in the right arm. The patient developed a cold sore (previous history of cold sore related to stress), this cold sore was still ongoing and being treated with acyclovir. The patient developed shivering and was treated this with acetaminophen. The patient also developed feeling hot. The reporter does not have vaccine information for this adverse event. The reporter consented to follow up. This case is linked to the case US2020245649, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020245649:same reporter
Patient recieved flu vaccine in our depatment. After the flu was administered the patient left feeling fine. Around 5 minutes later the patient came back in stating she felt dizzy, sweaty, breathing funny, and a weird taste in her mouth. We laid her down on the exam table and patient stated she felt better. BP 138/74. We sat patient up and gave her water. She stated she felt completely fine now. We stood patient up and BP 151/68. Walked patient to car and informed patient if she has any shortness of breath to call 911 and if she feels dizzy to lay down.
I brought him to the after hours care clinic, he was very lethargic, wasn't eating, had a high fever and a runny nose with a cough. They performed a flu test it came back negative. I came back to the ER 2 hours later and they ran another flu test it came back postive and then they sent him home saying there was nothing they could do. I later took him back and he was wheezing. I told them something was wrong that this wasn't how my son acts. They later admitted him and he was diagnosed with pneumonia and was put on oxygen.
At site of polio injection skin became red, itchy, warm to touch and tender. When student was seen on 5/11/07 Left upper arm was no longer warm to touch, only occasionally itchy, area of redness was 2.5 cm x 6 cm, no lump, non-tender, soft and cool to the touch.
Experienced chills beginning at 2am the following night, followed by a fever of 100.6 degree which peaked around 5am. Following this, I was fatigued and felt overall unwell and unable to do work until 4pm the next day (24 hours later).
I reconstituted the MENVEO with regular diluant. I am a new immunization nurse and I did not know that there was a liquid component to the vaccine.